PRAX logo

PRAX
Praxis Precision Medicines Inc

1,713
Mkt Cap
$8.8B
Volume
254,072.00
52W High
$356.00
52W Low
$28.79
PE Ratio
-23.48
PRAX Fundamentals
Price
$316.14
Prev Close
$320.24
Open
$325.17
50D MA
$314.41
Beta
1.00
Avg. Volume
436,105.25
EPS (Annual)
-$13.48
P/B
9.07
Rev/Employee
$0.00
$6,033.81
Loading...
Loading...
News
all
press releases
Praxis Precision Medicines (NASDAQ:PRAX) Upgraded to Strong-Buy at Raymond James Financial
Raymond James Financial raised Praxis Precision Medicines to a "strong-buy" rating in a report on Thursday...
MarketBeat·13h ago
News Placeholder
More News
News Placeholder
Raymond James Financial Initiates Coverage on Praxis Precision Medicines (NASDAQ:PRAX)
Raymond James Financial began coverage on shares of Praxis Precision Medicines in a research note on Friday. They issued a "strong-buy" rating and a $815.00 price target on the stock...
MarketBeat·1d ago
News Placeholder
JPMorgan Chase & Co. Grows Position in Praxis Precision Medicines, Inc. $PRAX
JPMorgan Chase & Co. raised its holdings in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 88.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,208 shares of the compan...
MarketBeat·3d ago
News Placeholder
HC Wainwright Reiterates Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)
HC Wainwright reaffirmed a "buy" rating and issued a $1,245.00 target price on shares of Praxis Precision Medicines in a research note on Tuesday...
MarketBeat·4d ago
News Placeholder
BTIG Research Reaffirms "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX)
BTIG Research reissued a "buy" rating and set a $843.00 target price on shares of Praxis Precision Medicines in a research report on Monday...
MarketBeat·5d ago
News Placeholder
Praxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In Trial
Praxis Precision Medicines shares are trading higher Monday after it announced positive results from the EMBRAVE Part A Trial of Elsunersen.read more...
Benzinga·5d ago
News Placeholder
Aberdeen Group plc Takes $39.79 Million Position in Praxis Precision Medicines, Inc. $PRAX
Aberdeen Group plc bought a new position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with...
MarketBeat·7d ago
News Placeholder
SG Americas Securities LLC Cuts Position in Praxis Precision Medicines, Inc. $PRAX
SG Americas Securities LLC lessened its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 26.2% during the fourth quarter, according to the company in its most recent Form...
MarketBeat·8d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Trading Up 13.4% - Time to Buy?
Praxis Precision Medicines (NASDAQ:PRAX) Trading 13.4% Higher - Time to Buy...
MarketBeat·11d ago
News Placeholder
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the nineteen ratings firms that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, one...
MarketBeat·13d ago
<
1
2
...
>

Latest PRAX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.